Edward (Ted) Clark MD MSc
@edclark75
Followers
593
Following
2K
Media
20
Statuses
348
Nephrologist who likes to visit the ICU. Works at @OttawaRenal. PI for @AlterAKItrial.
Ottawa, Canada
Joined March 2017
Excited to see this finally in press!!! Shout-out to coauthors @hswapnil @intensivistAk @OleksaRewa @edclark75 and to @EtienneMacedo and @RavindraLMehta1 whose prior version we built upon. @AJKDonline
#nephCC #nephcrit #critcareneph #AKI
https://t.co/TCXnQuZjWU
0
5
12
🎉Congratulations, Dr. @coryegoldstein! Winner of @uOttawa Faculty of Medicine's Best Paper Award 2024 for "The Ottawa Statementment implementation guidance document for cluster randomized trials in hemodialysis setting". Find more about it @
sway.cloud.microsoft
Weekly Research Info, Events, Funding Opportunities, and more
0
1
8
For more discussion and to put these findings into perspective, read the accompanying commentary from Greg Hundemer of @OttawaRenal and Hohsen Agharazhii 🔗 https://t.co/uV9bnngz7V
academic.oup.com
Primary aldosteronism (PA) is increasingly recognized as the most common and modifiable form of secondary hypertension.1 While historically considered a ra
The association between plasma aldosterone and intraglomerular hemodynamics in primary aldosteronism 🔗 https://t.co/1bwykiGPdv
1
4
7
ALTER-AKI Trial hit a major milestone this week with our 100th participant enrolled! @CCCTG_ @CNTN_RCEN #CTTG
0
3
6
Congrats to @lakeridgehealth critical care doc @shanfernands as lead author on this systematic review of the role of methylene blue in septic shock! Great team of investigators that will continue to work on better understanding of this therapy.
journals.lww.com
DATA SOURCES: We searched six databases (including PubMed, Embase, and Medline) from inception to January 10, 2024. STUDY SELECTION: We included randomized clinical trials (RCTs) of critically ill...
0
6
8
Best retrospective #POCUS study: Gaudreau-Simard M et al. Test characteristics of POCUS in patients with acute kidney injury. Ultrasound J 2024;16:15. @MathildeGSimard @uOttawamwoo @sydneyruller @epi_rad @edclark75 @krw127 🔗 https://t.co/3OdaQBrqwX
1
3
5
Congrats to the @KingstonHSC @queensccm team for enrolling their 1st patient into @AlterAKItrial!! @HanleyMichaela @jgordonboyd @jeanniecallum @drsamsilver @docsibley @muscedej
@CCCTG_ @CNTN_RCEN #CTTG
0
3
7
Kudos to the ICU research team @niagarahealth for randomizing their first patient into the ALTER-AKI trial this past week! @JenniferTsang12 @CCIRNet
@CCCTG_ @CNTN_RCEN #CTTG
0
2
7
Sharing our latest work characterizing CHIP as a risk factor for acute kidney injury (AKI) using human cohort data and mouse models. Published today in @NatureMedicine: https://t.co/k2ZbfD44Ew
16
34
127
Finally in print! Part 1 of our QI study - describing the use and test characteristics of POCUS in patients with AKI! Stay tuned for part 2! @uOttawamwoo @sydneyruller @krw127 @epi_rad @edclark75 @OttawaIM
https://t.co/YvTCMOfbdD
theultrasoundjournal.springeropen.com
Background Acute kidney injury is a common disorder that is associated with significant morbidity and mortality. Point-of-care ultrasonography (PoCUS) is an imaging modality performed at the bedside...
0
3
20
Last week was a big one for ALTER-AKI: received great news from @CIHR_IRSC AND first participants at @HeartInstitute were enrolled by all-star coordinator #RebeccaPorteous.
0
2
6
1/3 We are excited to announce that the ALTER-AKI trial has been funded by @CIHR_IRSC! This will allow for the trial to be expanded, and completed, across🇨🇦. @CCCTG_ @CNTN_RCEN #CTTG @CCIRNet
@edclark75 @JeannieCallum @DrRonWald @DrSeanBagshaw
2
9
27